<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="42497" whole_study_id="21283" phs="001514" v="2" p="1" createDate="2021-06-16T08:55:21-05:00" completedByGPADate="2021-06-22T09:16:45-05:00" modDate="2022-01-25T16:16:28-05:00" maxParentChildStudyModDate="2022-01-25T16:16:28-05:00" handle="TOPMed_WGS_Walk_PHaSST" num_participants="600"><StudyInfo accession="phs001514.v2.p1" parentAccession="phs001514.v2.p1"><BioProject id="PRJNA423124" entrez_id="423124" type="bp_admin_access"/><BioProject id="PRJNA423125" entrez_id="423125" type="bp_data_submission"/><StudyNameEntrez>NHLBI TOPMed: Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy (Walk-PHaSST)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="cloud_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="genotype_calls_from_sequence"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>germline</StudyType><StudyType>genotype_calls_from_sequence</StudyType><StudyType>whole_genome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="YINGZEZHANG" aid="2" auth="eRA" login="YINGZEZHANG" fname="Yingze" mname="" lname="Zhang" email="zhangy@upmc.edu"><Role allow_direct_access="true">PI</Role><Organization>UNIVERSITY OF PITTSBURGH AT PITTSBURGH</Organization></Person><Person nedid="0010146704" aid="1" auth="cit" login="qasbap" fname="Pankaj" mname="" lname="Qasba" email="qasbap@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Mehdi" lname="Nouraie" email="nouraies@upmc.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="NOURAIE" aid="2" auth="eRA" login="NOURAIE" fname="Seyed Mehdi" lname="Nouraie" email="snouraie@pitt.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF PITTSBURGH AT PITTSBURGH</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="MGLADWIN" aid="2" auth="eRA" login="MGLADWIN" fname="Mark" mname="" lname="Gladwin" email="gladwinmt@upmc.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF PITTSBURGH AT PITTSBURGH</Organization></Person><Person nedid="VGORDEUK" aid="2" auth="eRA" login="VGORDEUK" fname="Victor" mname="" lname="Gordeuk" email="vgordeuk@uic.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOHOWARD UNIVERSITY</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The TOPMed acknowledgement statement can be found at: https://topmed.nhlbi.nih.gov/acknowledgements . In addition please include: "We thank Dr. Mark Gladwin and the investigators of the Walk-PHaSST study and the patients who participated in the study. We also thanks the Walk-PHaSST clinical site team: Albert Einstein College of Medicine: Jane Little and Verlene Davis; Columbia University: Robyn Barst, Erika Rosenzweig, Margaret Lee and Daniela Brady; UCSF Benioff Children's Hospital Oakland: Claudia Morris, Ward Hagar, Lisa Lavrisha, Howard Rosenfeld, and Elliott Vichinsky; Children&#8217;s Hospital of Pittsburgh of UPMC: Regina McCollum; Hammersmith Hospital, London: Sally Davies, Gaia Mahalingam, Sharon Meehan, Ofelia Lebanto, and Ines Cabrita; Howard University: Victor Gordeuk, Oswaldo Castro, Onyinye Onyekwere, Vandana Sachdev, Alvin Thomas, Gladys Onojobi, Sharmin Diaz, Margaret Fadojutimi-Akinsiku, and Randa Aladdin; Johns Hopkins University: Reda Girgis, Sophie Lanzkron and Durrant Barasa; NHLBI: Mark Gladwin, Greg Kato, James Taylor, Wynona Coles, Catherine Seamon, Mary Hall, Amy Chi, Cynthia Brenneman, Wen Li, and Erin Smith; University of Colorado: Kathryn Hassell, David Badesch, Deb McCollister and Julie McAfee; University of Illinois at Chicago: Dean Schraufnagel, Robert Molokie, George Kondos, Patricia Cole-Saffold, and Lani Krauz; National Heart &amp; Lung Institute, Imperial College London: Simon Gibbs. Thanks also to the data coordination center team from Rho, Inc.: Nancy Yovetich, Rob Woolson, Jamie Spencer, Christopher Woods, Karen Kesler, Vickie Coble, and Ronald W. Helms. We also thank Dr. Yingze Zhang for directing the Walk-PHaSST repository and Dr. Mehdi Nouraie for maintaining the Walk-PHaSST database and Dr. Jonathan Goldsmith as a NIH program director for this study. Special thanks to the volunteers who participated in the Walk-PHaSST study.
This project was funded with federal funds from the NHLBI, NIH, Department of Health and Human Services, under contract HHSN268200617182C. This study is registered at www.clinicaltrials.gov as NCT00492531. Detail description of the study was published in Blood, 2011 118:855-864, Machado et al 'Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity'."
</acknowledgement_statement><ic_specific_access_term>There are two consent groups for this study: (1) HMB-IRB-PUB-COL-NPU-MDS and (2) DS-SCD-IRB-PUB-COL-NPU-MDS-RD.  

(1) For HMB-IRB-PUB-COL-NPU-MDS-GSO: 
Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval (please note only full or expedited approvals will be accepted).
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).
Use of the data is limited to genetic studies only.

(2) For DS-SCD-IRB-PUB-COL-NPU-MDS-RD:
Use of the data is limited to genetic studies of sickle cell disease and related conditions such as blood pressure, blood flow, lungs, high blood pressure in the lungs.
Requestor must provide documentation of local IRB approval (please note only full or expedited approvals will be accepted).
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access_timeout_extend" gsr_mode_label="Controlled-access (institution requested additional time)"/><ConsentGroup uid="2179" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, PUB, COL, NPU, MDS, GSO)" name="HMB-IRB-PUB-COL-NPU-MDS-GSO" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).
Use of the data is limited to genetic studies only.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2180" CGType="cg_class_DS" title="Disease-Specific (Sickle Cell Disease, IRB, PUB, COL, NPU, MDS, RD)" name="DS-SCD-IRB-PUB-COL-NPU-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use of the data must be related to Sickle Cell Disease and related disorders.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the data is limited to genetic studies of sickle cell disease and related conditions such as blood pressure, blood flow, lungs, high blood pressure in the lungs. </Use-Restriction></ConsentGroup><ConsentGroup uid="2181" CGType="cg_class_EA" title="Exchange Area (IRB, PUB, COL, NPU, MDS, RD)" name="EA-IRB-PUB-COL-NPU-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use by NHLBI TOPMed WGS study investigators only.  There are two consent groups for this study:   HMB-IRB-PUB-COL-NPU-MDS and DS-SCD-IRB-PUB-COL-NPU-MDS-RD
1)  HMB-IRB-PUB-COL-NPU-MDS-GSO
Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).
Use of the data is limited to genetic studies only.

2)  DS-SCD-IRB-PUB-COL-NPU-MDS-RD
Use of the data must be related to the specified disease &#8211; Sickle cell disease
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms)
Use of the data is limited to genetic studies of sickle cell disease and related conditions such as blood pressure, blood flow, lungs, high blood pressure in the lungs.

</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="21283" whole_study_id="21283" phs="001514" v="1" p="1" createDate="2016-09-07T11:56:37-05:00" completedByGPADate="2016-09-30T13:36:15-05:00" modDate="2021-06-16T08:55:30-05:00" maxParentChildStudyModDate="2021-06-16T08:55:30-05:00" handle="TOPMed_WGS_Walk_PHaSST" num_participants="600"><StudyInfo accession="phs001514.v1.p1" parentAccession="phs001514.v1.p1"><BioProject id="PRJNA423124" entrez_id="423124" type="bp_admin_access"/><BioProject id="PRJNA423125" entrez_id="423125" type="bp_data_submission"/><StudyNameEntrez>NHLBI TOPMed: Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy (Walk-PHaSST)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="cloud_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="genotype_calls_from_sequence"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>germline</StudyType><StudyType>genotype_calls_from_sequence</StudyType><StudyType>whole_genome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="YINGZEZHANG" aid="2" auth="eRA" login="YINGZEZHANG" fname="Yingze" mname="" lname="Zhang" email="zhangy@upmc.edu"><Role allow_direct_access="true">PI</Role><Organization>UNIVERSITY OF PITTSBURGH AT PITTSBURGH</Organization></Person><Person nedid="0010146704" aid="1" auth="cit" login="qasbap" fname="Pankaj" mname="" lname="Qasba" email="qasbap@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Mehdi" lname="Nouraie" email="nouraies@upmc.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="NOURAIE" aid="2" auth="eRA" login="NOURAIE" fname="Seyed Mehdi" lname="Nouraie" email="snouraie@pitt.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF PITTSBURGH AT PITTSBURGH</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="MGLADWIN" aid="2" auth="eRA" login="MGLADWIN" fname="Mark" mname="" lname="Gladwin" email="gladwinmt@upmc.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF PITTSBURGH AT PITTSBURGH</Organization></Person><Person nedid="VGORDEUK" aid="2" auth="eRA" login="VGORDEUK" fname="Victor" mname="" lname="Gordeuk" email="vgordeuk@uic.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOHOWARD UNIVERSITY</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2000452640" aid="1" auth="cit" login="chensh2" fname="Shu Hui" mname="" lname="Chen" email="shuhui.chen@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The TOPMed acknowledgement statement can be found at: https://www.nhlbiwgs.org/acknowledgements . In addition please include: "We thank Dr. Mark Gladwin and the investigators of the Walk-PHaSST study and the patients who participated in the study. We also thanks the Walk-PHaSST clinical site team: Albert Einstein College of Medicine: Jane Little and Verlene Davis; Columbia University: Robyn Barst, Erika Rosenzweig, Margaret Lee and Daniela Brady; UCSF Benioff Children's Hospital Oakland: Claudia Morris, Ward Hagar, Lisa Lavrisha, Howard Rosenfeld, and Elliott Vichinsky; Children&#8217;s Hospital of Pittsburgh of UPMC: Regina McCollum; Hammersmith Hospital, London: Sally Davies, Gaia Mahalingam, Sharon Meehan, Ofelia Lebanto, and Ines Cabrita; Howard University: Victor Gordeuk, Oswaldo Castro, Onyinye Onyekwere, Vandana Sachdev, Alvin Thomas, Gladys Onojobi, Sharmin Diaz, Margaret Fadojutimi-Akinsiku, and Randa Aladdin; Johns Hopkins University: Reda Girgis, Sophie Lanzkron and Durrant Barasa; NHLBI: Mark Gladwin, Greg Kato, James Taylor, Wynona Coles, Catherine Seamon, Mary Hall, Amy Chi, Cynthia Brenneman, Wen Li, and Erin Smith; University of Colorado: Kathryn Hassell, David Badesch, Deb McCollister and Julie McAfee; University of Illinois at Chicago: Dean Schraufnagel, Robert Molokie, George Kondos, Patricia Cole-Saffold, and Lani Krauz; National Heart &amp; Lung Institute, Imperial College London: Simon Gibbs. Thanks also to the data coordination center team from Rho, Inc.: Nancy Yovetich, Rob Woolson, Jamie Spencer, Christopher Woods, Karen Kesler, Vickie Coble, and Ronald W. Helms. We also thank Dr. Yingze Zhang for directing the Walk-PHaSST repository and Dr. Mehdi Nouraie for maintaining the Walk-PHaSST database and Dr. Jonathan Goldsmith as a NIH program director for this study. Special thanks to the volunteers who participated in the Walk-PHaSST study.
This project was funded with federal funds from the NHLBI, NIH, Department of Health and Human Services, under contract HHSN268200617182C. This study is registered at www.clinicaltrials.gov as NCT00492531. Detail description of the study was published in Blood, 2011 118:855-864, Machado et al 'Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity'."
</acknowledgement_statement><ic_specific_access_term>There are two consent groups for this study: (1) HMB-IRB-PUB-COL-NPU-MDS and (2) DS-SCD-IRB-PUB-COL-NPU-MDS-RD.  

(1) For HMB-IRB-PUB-COL-NPU-MDS-GSO: 
Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval (please note only full or expedited approvals will be accepted).
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).
Use of the data is limited to genetic studies only.

(2) For DS-SCD-IRB-PUB-COL-NPU-MDS-RD:
Use of the data is limited to genetic studies of sickle cell disease and related conditions such as blood pressure, blood flow, lungs, high blood pressure in the lungs.
Requestor must provide documentation of local IRB approval (please note only full or expedited approvals will be accepted).
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access_timeout_extend" gsr_mode_label="Controlled-access (institution requested additional time)"/><ConsentGroup uid="2179" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, PUB, COL, NPU, MDS, GSO)" name="HMB-IRB-PUB-COL-NPU-MDS-GSO" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).
Use of the data is limited to genetic studies only.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2180" CGType="cg_class_DS" title="Disease-Specific (Sickle Cell Disease, IRB, PUB, COL, NPU, MDS, RD)" name="DS-SCD-IRB-PUB-COL-NPU-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use of the data must be related to Sickle Cell Disease and related disorders.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the data is limited to genetic studies of sickle cell disease and related conditions such as blood pressure, blood flow, lungs, high blood pressure in the lungs. </Use-Restriction></ConsentGroup><ConsentGroup uid="2181" CGType="cg_class_EA" title="Exchange Area (IRB, PUB, COL, NPU, MDS, RD)" name="EA-IRB-PUB-COL-NPU-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use by NHLBI TOPMed WGS study investigators only.  There are two consent groups for this study:   HMB-IRB-PUB-COL-NPU-MDS and DS-SCD-IRB-PUB-COL-NPU-MDS-RD
1)  HMB-IRB-PUB-COL-NPU-MDS-GSO
Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).
Use of the data is limited to genetic studies only.

2)  DS-SCD-IRB-PUB-COL-NPU-MDS-RD
Use of the data must be related to the specified disease &#8211; Sickle cell disease
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms)
Use of the data is limited to genetic studies of sickle cell disease and related conditions such as blood pressure, blood flow, lungs, high blood pressure in the lungs.

</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>